Bioxcel therapeutics, inc. shareholder reminder: kessler topaz meltzer & check, llp reminds btai investors of securities fraud class action lawsuit filed on their behalf

Radnor, pa.--(business wire)-- #classaction--the law firm of kessler topaz meltzer & check, llp (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the united states district court for the district of connecticut against bioxcel therapeutics, inc. (“bioxcel”) (nasdaq: btai). the action charges bioxcel with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. as a.
BTAI Ratings Summary
BTAI Quant Ranking